Skip to Content

Treatment After Kidney Surgery

Everolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study

Objective

One group will received Everolimus for 54 weeks, the other group will get a look alike pill for 54 weeks.

IRB Protocol Number
SWOG S0931
Principal Investigator(s)
Charles Catcher, MD

Clinical Trial Categories

  • Genitourinary Cancer
Contact
Margaret White, RN OCN, CC at 603-232-8908
How to Participate

Inclusion Criteria:

  • Participants must be considered high risk;
  • Must have at least part of the kidney surgically removed;
  • Must start treatment within 84 days of the kidney operation.

Exclusion Criteria:

  • Cannot have any sign of cancer anywhere else in the body. 

Location

  • Payson Center for Cancer Care
    250 Pleasant Street
    Concord, NH 03301
    Main: 603-230-6000